Technical Analysis for EGLT - Egalet Corp

Grade Last Price % Change Price Change
grade F 0.0315 -63.37% -0.0545
EGLT closed down 63.37 percent on Wednesday, October 31, 2018, on 8.87 times normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical EGLT trend table...

Date Alert Name Type % Chg
Older signals for EGLT ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:


Egalet Corporation, a specialty pharmaceutical company, develops, manufactures, and commercializes treatments for patients with pain and other conditions. It has licensed three approved pain products, such as SPRIX Nasal Spray, a non-steroidal anti-inflammatory drug indicated in adult patients for the short-term management of moderate to moderately severe pain that requires analgesia at the opioid level; OXAYDO, an immediate-release oxycodone product designed to discourage abuse via snorting for the management of acute and chronic pain severe enough to require an opioid analgesic, and for which alternative treatments are inadequate; and ARYMO ER, an extended-release (ER) morphine product formulated with abuse-deterrent (AD) properties for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment and for which alternative treatment options are inadequate. The company is also developing Egalet-002, a Guardian Technology AD, ER, oral oxycodone formulation, which is in Phase III clinical trials for the same indication as ARYMO ER. In addition, its other products include Egalet-003, an AD stimulant product candidate; and Egalet-004, an AD, ER hydrocodone-based product candidate. The company has a collaboration and license agreement with Acura Pharmaceuticals, Inc. to commercialize OXAYDO tablets; and Septodont, Inc. to promote SPRIX Nasal Spray. Egalet Corporation was founded in 2010 and is headquartered in Wayne, Pennsylvania.
RTT Euphoriants Pharmaceutical Psychoactive Drugs Chemical Compounds Morphinans Opioids Heroin Morphine Oxycodone Acute And Chronic Pain Analgesic Hydrocodone Pain Products Short Term Management Alternative Treatments Immediate Release Oxycodone Product Morphine Product Nasal Spray Sprix Nasal Spray

Is EGLT a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength


Indicator Value
52 Week High 0.1855
52 Week Low 0.031
Average Volume 587,974
200-Day Moving Average 0.0000
50-Day Moving Average 0.0000
20-Day Moving Average 0.1080
10-Day Moving Average 0.0912
Average True Range 0.0279
ADX 23.44
+DI 8.2220
-DI 26.9784
Chandelier Exit (Long, 3 ATRs ) 0.0743
Chandelier Exit (Short, 3 ATRs ) 0.1147
Upper Bollinger Band 0.1583
Lower Bollinger Band 0.0577
Percent B (%b) -0.26
BandWidth 93.1481
MACD Line -0.0193
MACD Signal Line -0.0139
MACD Histogram -0.0055
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.1350
Resistance 3 (R3) 0.1463 0.1232 0.1178
Resistance 2 (R2) 0.1232 0.0968 0.1175 0.1120
Resistance 1 (R1) 0.0773 0.0805 0.0658 0.0660 0.1062
Pivot Point 0.0542 0.0542 0.0484 0.0485 0.0542
Support 1 (S1) 0.0083 0.0278 -0.0033 -0.0030 -0.0432
Support 2 (S2) -0.0148 0.0115 -0.0205 -0.0490
Support 3 (S3) -0.0607 -0.0148 -0.0548
Support 4 (S4) -0.0720